Home Cart 0 Sign in  
X

[ CAS No. 62484-12-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 62484-12-2
Chemical Structure| 62484-12-2
Chemical Structure| 62484-12-2
Structure of 62484-12-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62484-12-2 ]

Related Doc. of [ 62484-12-2 ]

Alternatived Products of [ 62484-12-2 ]

Product Details of [ 62484-12-2 ]

CAS No. :62484-12-2 MDL No. :MFCD18427204
Formula : C9H8N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :BTEAXSZDTYHOGC-UHFFFAOYSA-N
M.W : 192.17 Pubchem ID :19604241
Synonyms :

Calculated chemistry of [ 62484-12-2 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 50.08
TPSA : 75.47 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.43 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.79
Log Po/w (XLOGP3) : 1.47
Log Po/w (WLOGP) : 1.05
Log Po/w (MLOGP) : 0.24
Log Po/w (SILICOS-IT) : 0.93
Consensus Log Po/w : 1.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.42
Solubility : 0.73 mg/ml ; 0.0038 mol/l
Class : Soluble
Log S (Ali) : -2.66
Solubility : 0.419 mg/ml ; 0.00218 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.31
Solubility : 0.943 mg/ml ; 0.00491 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 62484-12-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62484-12-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62484-12-2 ]
  • Downstream synthetic route of [ 62484-12-2 ]

[ 62484-12-2 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 62484-12-2 ]
  • [ 62484-31-5 ]
YieldReaction ConditionsOperation in experiment
54% With trichlorophosphate In acetonitrile for 8 h; Reflux 7-methoxyquinazoline-2,4(lH,3H)dione (0.31 g; 1.6 mmol) was added to a solution of POC13(10 mL; 107 mmol) in 3 mL of acetonitrile and the mixture was heated to reflux for 8 h. The mixture was poured into ice water and was vigorously stirred and the resulting precipitate was filtered and dried. The precipitate was filtered through silica using dichloromethane to afford 9 as a white powder (0.201 g; 0.88 mmol; 54 percent). 1H NMR (500 MHz; DMSO) δ 8.1 (d, J=9.21 Hz, 1H, Ha4), 7.44 (dd, J=2.08, 9.26 Hz, 1H, Ha5), 7.38 (d, J=2.07 Hz, 1H, Ha7), 3.99 (s, 3H, Hbl). 13C NMR (125 MHz; DMSO) δ 166.2 (Ca6), 162.17 (Ca2), 158 (Cal), 154.9 (Ca8), 127.7 (Ca4), 122.95 (Ca5), 117.2 (Ca3), 106.5 (Ca7), 57 (Cbl). HRMS-ESI (m/z) calculated for C9H6C12N20: 227.9918 [M+H]+ ; found: 227.9935
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 42, p. 6081 - 6083
[2] Patent: WO2016/151144, 2016, A1, . Location in patent: Page/Page column 56
[3] Journal of the Chemical Society, 1948, p. 1759,1765
[4] Journal of the Chemical Society, 1947, p. 890,894
[5] Patent: US5688803, 1997, A,
[6] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
  • 2
  • [ 62484-12-2 ]
  • [ 62484-31-5 ]
YieldReaction ConditionsOperation in experiment
0.64 g Reflux <Step 2> 2,4-dichloro-7-methoxyquinazoline
A mixture of 7-methoxyquinazolin-2,4-diol (3 g, 15.6 mmol) prepared in Step 1 and phosphorus oxychloride (10 ml) was stirred at reflux overnight.
After cooling the reaction mixture to room temperature, the same was added into ice water, and basified to pH 7-8 by using sodium bicarbonate.
The aqueous layer was extracted with dichloromethane, and the organic layer was dried on anhydrous magnesium sulfate and concentrated under reduced pressure.
The resulting residue was purified with silica gel column chromatography (n-hexane/ethyl acetate=10/1) to give the titled compound (0.64 g) as a white solid.
1H NMR (400 MHz, CDCl3) δ 8.12 (d, 1H), 7.37-7.20 (m, 2H), 3.99 (s, 3H).
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 14, p. 7021 - 7032
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 144 - 158
[3] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1452 - 1465
[4] Patent: US2016/90374, 2016, A1, . Location in patent: Paragraph 0218; 0219
  • 3
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, # 48, p. 17605 - 17614
[2] Journal of the Chemical Society, 1947, p. 890,894
[3] Patent: US5688803, 1997, A,
  • 4
  • [ 57-13-6 ]
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
YieldReaction ConditionsOperation in experiment
48% at 155℃; for 16 h; A mixture of 2-amino-4-methoxybenzoic acid (1 g; 5.98 mmol) and urea (7.18 g; 120 mmol) was stirred at 155°C for 16 h. The reaction mixture was cooled to 100°C and then 3 mL of water was added. The mixture was cooled to room temperature and was filtered. 30 mL of 1 mol/L NaOH aqueous solution was added to dissolve the precipitate. After one hour, 4.2 mL of acetic acid was added dropwise and the resulting light brown precipitate was filtered and dried. 8 was obtained as a light brown powder (0.55 g; 2.9 mmol; 48 percent). 1H NMR (500 MHz; DMSO) δ 11.10 (brs, 1H, HNH), 10.55 (brs, 1H, HNH), 7.8 (d, J=8.63 Hz, 1H, Ha4), 6.77 (dd, J=2.44, 8.84 Hz, 1H, Ha5), 6.64 (d, J=2.43 Hz, 1H, Ha7), 3.82 (s, 3H, Hbl). 13C NMR (125 MHz; DMSO) δ 164.8 (Ca6), 162.8 (Ca2), 151 (Cal), 143.3 (Ca8), 129.3 (Ca4), 111 (Ca5), 108.2 (Ca3), 98.8 (Ca7), 56.1 (Cbl). HRMS-ESI (m/z) calculated for C9H8N203: 193.0489 [M+H]+ ; found: 193.0511
Reference: [1] Patent: WO2016/151144, 2016, A1, . Location in patent: Page/Page column 55; 56
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5141 - 5156
  • 5
  • [ 590-28-3 ]
  • [ 4294-95-5 ]
  • [ 62484-12-2 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 42, p. 6081 - 6083
  • 6
  • [ 1072895-72-7 ]
  • [ 536-90-3 ]
  • [ 62484-12-2 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 42, p. 6081 - 6083
  • 7
  • [ 409315-39-5 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 1759,1765
  • 8
  • [ 857600-58-9 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the Chemical Society, 1947, p. 890,894
  • 9
  • [ 38487-91-1 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 1759,1765
  • 10
  • [ 38469-83-9 ]
  • [ 62484-12-2 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 1759,1765
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 62484-12-2 ]

Ethers

Chemical Structure| 19181-64-7

[ 19181-64-7 ]

6-Methoxyquinazolin-4-ol

Similarity: 0.92

Chemical Structure| 674810-96-9

[ 674810-96-9 ]

4-(4-Methoxyphenyl)pyrimidin-2-ol

Similarity: 0.85

Chemical Structure| 179688-01-8

[ 179688-01-8 ]

7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one

Similarity: 0.83

Chemical Structure| 55496-52-1

[ 55496-52-1 ]

4-Chloro-7-methoxyquinazoline

Similarity: 0.73

Chemical Structure| 99844-02-7

[ 99844-02-7 ]

4-(4-Methoxyphenyl)pyrimidin-2-amine

Similarity: 0.72

Alcohols

Chemical Structure| 19181-64-7

[ 19181-64-7 ]

6-Methoxyquinazolin-4-ol

Similarity: 0.92

Chemical Structure| 674810-96-9

[ 674810-96-9 ]

4-(4-Methoxyphenyl)pyrimidin-2-ol

Similarity: 0.85

Chemical Structure| 179688-01-8

[ 179688-01-8 ]

7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one

Similarity: 0.83

Chemical Structure| 114703-12-7

[ 114703-12-7 ]

7-Bromoquinazoline-2,4(1H,3H)-dione

Similarity: 0.80

Chemical Structure| 1769-24-0

[ 1769-24-0 ]

2-Methylquinazolin-4-ol

Similarity: 0.77

Related Parent Nucleus of
[ 62484-12-2 ]

Quinazolines

Chemical Structure| 19181-64-7

[ 19181-64-7 ]

6-Methoxyquinazolin-4-ol

Similarity: 0.92

Chemical Structure| 179688-01-8

[ 179688-01-8 ]

7-(Benzyloxy)-6-methoxyquinazolin-4(3H)-one

Similarity: 0.83

Chemical Structure| 114703-12-7

[ 114703-12-7 ]

7-Bromoquinazoline-2,4(1H,3H)-dione

Similarity: 0.80

Chemical Structure| 491-36-1

[ 491-36-1 ]

Quinazolin-4(3H)-one

Similarity: 0.79

Chemical Structure| 1769-24-0

[ 1769-24-0 ]

2-Methylquinazolin-4-ol

Similarity: 0.77